Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly Diagnosed Chemotherapy Naive Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. The Observational ROADMAT-CAT-MM Study

Despina Fotiou,Theodoros Sergentanis,Loula Papageorgiou,Maria Gavriatopoulou,Theodora Psaltopoulou,Patrick VanDreden,Annette Larsen,Ismail Elalamy,Efstathios Kastritis,Kimon Stamatelopoulos,Evangelos Terpos, Meletios Dimopoulos,Grigoris Gerotziafas

THROMBOSIS RESEARCH（2018）

引用 0|浏览5

暂无评分

摘要

Research has focused on the implications of platelet, endothelial cell and blood coagulation activation in the risk of venous thromboembolism (VTE) in patients with multiple myeloma (MM). This common complication in the newly diagnosed MM (NDMM) patients remains high despite guideline-based thromboprophylaxis use.

查看译文

关键词

Multiple Myeloma,Cancer-associated thrombosis,Risk assessment model,Thromboprophylaxis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要